Aesthetic Medical International Holdings Group (AIH) Stock Price, News & Analysis

Company Overview

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China and Singapore. The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and ultraviolet light treatments. It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. The company was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.13 to $0.66
• 52-Week Range: N/A
• Volume: 184,300 shs
• Average Volume: 173,623 shs
• Market Capitalization: $15.93 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AIH Stock Analysis - Frequently Asked Questions

How were Aesthetic Medical International Holdings Group's earnings last quarter?

Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) posted its quarterly earnings data on Sunday, November, 29th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.61 by $0.51. The company had revenue of $41.43 million for the quarter.

When did Aesthetic Medical International Holdings Group IPO?

Aesthetic Medical International Holdings Group (AIH) raised $30 million in an initial public offering on Friday, October 25th 2019. The company issued 2,500,000 shares at $11.00-$13.00 per share. Cantor, Haitong International and Prime Number Capital served as the underwriters for the IPO and Maxim Group, CMBI and Zinvest Global were co-managers.

What other stocks do shareholders of Aesthetic Medical International Holdings Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aesthetic Medical International Holdings Group investors own include Kinross Gold (KGC), Oncobiologics (OTLK), Aptose Biosciences (APTO), Bristol Myers Squibb (BMY), Carnival (CCL), Corbus Pharmaceuticals (CRBP) and Dynavax Technologies (DVAX).

Company Calendar

• Last Earnings: 11/29/2020
• Today: 8/19/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Specialty outpatient clinics, not elsewhere classified
• Sub-Industry: N/A
• Current Symbol: NASDAQ:AIH
• CIK: 1757143
• Web: ir.aihgroup.net
• Phone: 86-755-2559-8065
• Fax: N/A
• Employees: 1,286
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.93
• Current Ratio: 0.27
• Quick Ratio: 0.23

Sales & Book Value

• Annual Sales: $682.59 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 4.34
• Book Value: $0.10 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 47,788,000
• Free Float: 21,457,000
• Market Cap: $15.93 million
• Optionable: Not Optionable
• Beta: -0.21